In the recent SOUL trial, the GLP-1 drug reduced the risk of MACE by 14% over 4 years. Next up: a possible obesity indication ...

WASHINGTON - If you've ever tried to lose weight, you know the feeling of constantly thinking about food. Dreaming of lunch ...

Anti-obesity medication semaglutide may help to prevent heart attacks and other major cardiac events regardless of how much ...

Semaglutide produces sustained weight and fat loss while preserving lean mass and metabolic efficiency, highlighting its ...

The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...

Wegovy and Ozempic appear to do more than reduce appetite—they quiet the “food noise” that fuels constant cravings.

There's growing interest among women to take GLP-1 drugs like semaglutide for weight loss after giving birth and while ...

Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, according to a new framework for the pharmacological treatment of obesity ...

Why Am I Still Hungry on Semaglutide? Reasons & What to Do Semaglutide — the active ingredient in Ozempic®, Wegovy®, and ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Can You Take Semaglutide While Breastfeeding? Key takeaways ...